| 000 | 01228 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517115840.0 | ||
| 264 | 0 | _c20170711 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1744-7682 | ||
| 024 | 7 |
_a10.1080/14712598.2016.1240780 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRendell, Marc S | |
| 245 | 0 | 0 |
_aAlbiglutide: a unique GLP-1 receptor agonist. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _c12 2016 |
||
| 300 |
_a1557-1569 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xadministration & dosage |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 16 _gno. 12 _gp. 1557-1569 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14712598.2016.1240780 _zAvailable from publisher's website |
| 999 |
_c26460583 _d26460583 |
||